OCEANS Trial: Bevacizumab Maintenance in Platinum Sensitive Recurrence Last updated on Jul 28, 2024 Previous MITO 16B/MANGO-OV2/ENGOT-OV17: Bev Maintenance with Platinum Doublets in Platinum-sensitive Recurrence Next Platinum Sensitive Recurrent Ovarian Cancer
